WuXi Biologics
Offering End-to-End Solutions
WuXi Vaccines offers extensive capabilities and capacity in the development and GMP manufacturing of live-attenuated viral vaccines and viral vectored vaccines in BSL-2 facilities. GMP production capabilities include single-use bioreactors up to 500 L, oRABS and Isolator technology for fill and finish, and quality control.
DS Manufacturing
Suspension Cell Culture
Cell Culture
Manufacturing Capacity for Viral Vaccines
Facilities | CCS | Unit/Batch Liquid product, 8 hours filling |
Unit/Batch Lyo product |
DP16 | 2R | 144,000 | 21,920 |
10R | 96,000 | 9,490 | |
20R | 62,400 | 6,195 | |
DP17 | 2R | 240,000 | 300,000 |
10R | 192,000 | 129,000 | |
20R | 114,000 | 84,000 |
SYNTEGON® Automatic Vial Filling Line
Services
|
|
Employees
|
|
Facilities
|
|
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?